Moderna's vaccine is 90fective at protecting against infection six months after the final dose

New data from the phase III clinical trial showed Moderna was 90% effective at preventing COVID-19 infection six months after the second dose and 95% at preventing severe disease.

Moderna's vaccine is 90fective at protecting against infection six months after the final dose
New data from the phase III clinical trial showed Moderna was 90% effective at preventing COVID-19 infection six months after the second dose and 95% at preventing severe disease.